This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 SC Cunnane , M Plourde , F Pifferi , (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48, 239–256.
2 M Fotuhi , P Mohassel & K Yaffe (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 5, 140–152.
6 JG Robinson , N Ijioma & W Harris (2010) Omega-3 fatty acids and cognitive function in women. Womens Health (Lond Engl) 6, 119–134.
8 R Uauy & AD Dangour (2006) Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev S24–33, 64, S72–S91.
11 AD Dangour , E Allen , D Elbourne , (2009) Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. J Nutr Health Aging 13, 198–202.
13 A Cherubini , C Andres-Lacueva , A Martin , (2007) Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 62, 1120–1126.
15 EJ Schaefer , V Bongard , AS Beiser , (2006) Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63, 1545–1550.
17 P Barberger-Gateau , L Letenneur , V Deschamps , (2002) Fish, meat, and risk of dementia: cohort study. Bmj 325, 932–933.
18 MC Morris , DA Evans , JL Bienias , (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60, 940–946.
20 EE Devore , F Grodstein , FJ van Rooij , (2009) Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 90, 170–176.
21 E Kesse-Guyot , S Peneau , M Ferry , (2011) Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive function. J Nutr Health Aging 15, 115–120.
25 JM Geleijnse
, EJ Giltay
& D Kromhout
) Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients
. Alzheimers Dement
26 O van de Rest , JM Geleijnse , FJ Kok , (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430–438.
28 K Yurko-Mauro , D McCarthy , D Rom , (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6, 456–464.
30 JF Quinn , R Raman , RG Thomas , (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. Jama 304, 1903–1911.
31 D Kromhout , EJ Giltay & JM Geleijnse (2010) n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363, 2015–2026.
32 F Calon , GP Lim , F Yang , (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633–645.
33 CV Rojas , JI Martinez , I Flores , (2003) Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid. Invest Ophthalmol Vis Sci 44, 3170–3177.
34 NG Bazan (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29, 263–271.
35 GM Cole & SA Frautschy (2010) DHA may prevent age-related dementia. J Nutr 140, 869–874.
37 I Elmadfa & M Kornsteiner (2009) Dietary fat intake–a global perspective. Ann Nutr Metab 54, Suppl. 1, 8–14.
38 DA Lawlor , G Davey Smith , D Kundu , (2004) Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 363, 1724–1727.
39 AD Dangour , E Allen , M Richards , (2010) Design considerations in long-term intervention studies for the prevention of cognitive decline or dementia. Nutr Rev 68, Suppl. 1, S16–S21.